Clinical Trial Update: Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin and Ezetimibe to Atorvastatin Coadministered With Ezetimibe in Subjects With Multiple Abnormal Lipid (Fat) Levels in the Blood [Phase 3]

View source ↗

Summary

Phase 3 safety and efficacy study comparing ABT-335 coadministered with atorvastatin and ezetimibe versus atorvastatin with ezetimibe in subjects with multiple …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Combined Dyslipidemia
• Coronary Heart Disease
• Dyslipidemias
• Mixed Dyslipidemia

Drugs mentioned

• ABT-335
• Lipitor (atorvastatin)
• Zetia (ezetimibe)

Snippet

Sponsor: Abbott | Conditions: Dyslipidemias, Coronary Heart Disease | Phase 3 | Status: COMPLETED | Results posted: 2009-11-05